Literature DB >> 6483072

Clinicopathological study of acute subdural haematoma in the chronic healing stage. Clinical, histological and ultrastructural comparisons with chronic subdural haematoma.

T Yamashima, S Yamamoto.   

Abstract

Seven cases of acute subdural haematoma in the chronic healing stage, were studied clinicopathologically. Operation was not performed until 17-30 days after major trauma, and revealed subdural granulation tissue of irregular thickness, but no visible inner membranes. Although this capsule contained blood pigment and numerous macrophages, new haemorrhagic foci or eosinophilic infiltrations were extremely rare. Capsular vessels generally had thick vascular walls, distinct basement membranes and tight endothelial junctions. Perivascular blood substance was presumably not secondary haemorrhage from these vessels, but residue from the acute subdural haematoma itself. The possibility of transition from this haematoma to chronic subdural haematoma is discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6483072     DOI: 10.1055/s-2008-1053668

Source DB:  PubMed          Journal:  Neurochirurgia (Stuttg)        ISSN: 0028-3819


  3 in total

1.  Risk Factors of Chronic Subdural Hematoma Progression after Conservative Management of Cases with Initially Acute Subdural Hematoma.

Authors:  Jong Joo Lee; Yusam Won; Taeyoung Yang; Sion Kim; Chun-Sik Choi; Jaeyoung Yang
Journal:  Korean J Neurotrauma       Date:  2015-10-31

Review 2.  Examining perinatal subdural haematoma as an aetiology of extra-axial hygroma and chronic subdural haematoma.

Authors:  Sverre Morten Zahl; Knut Wester; Steven Gabaeff
Journal:  Acta Paediatr       Date:  2019-11-13       Impact factor: 2.299

3.  Statins as a Medical Adjunct in the Surgical Management of Chronic Subdural Hematomas.

Authors:  Bradley S Guidry; Katherine A Kelly; Aaron M Yengo-Kahn; Matthews Lan; Alan R Tang; Silky Chotai; Peter Morone; Patrick D Kelly
Journal:  World Neurosurg       Date:  2021-02-18       Impact factor: 2.104

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.